View Older Stories View More Recent Stories

Dec 9, 2024 03:43PM Sonnet BioTherapeutics (SONN) Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Dec 9, 2024 03:42PM Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Dec 6, 2024 08:00AM Eyenovia Inc (EYEN) Prices 20.09M Share Offering at $0.0969
Dec 6, 2024 08:00AM Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering
Dec 4, 2024 05:30PM Ace Green Recycling, a Global Leader in Battery Recycling Technology, to Become a Public Company
Dec 4, 2024 05:30PM /C O R R E C T I O N -- ACE Green Recycling/
Dec 4, 2024 06:54AM Senti Biosciences, Inc. (SNTI) PT Raised to $12 at Chardan Capital Markets
Dec 2, 2024 03:49AM Chardan Capital Markets Downgrades Outlook Therapeutics Incs. (OTLK) to Neutral
Nov 27, 2024 07:14AM Chardan Capital Markets Reiterates Buy Rating on Arrowhead Pharma (ARWR)
Nov 25, 2024 08:00AM Eyenovia Inc (EYEN) Prices $1.3M Offering at $0.1076/sh
Nov 25, 2024 08:00AM Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering
Nov 20, 2024 09:19AM Forte Biosciences (FBRX) Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Nov 20, 2024 09:00AM Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Nov 14, 2024 04:15PM Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
Nov 14, 2024 08:33AM Clear Street Launches Equity Research Group
Nov 14, 2024 07:38AM Chardan Capital Markets Downgrades Allurion Technologies (ALUR) to Neutral
Nov 13, 2024 09:20PM Form SC 13G NewGenIvf Group Ltd Filed by: CHARDAN CAPITAL MARKETS LLC
Nov 13, 2024 09:17PM Form 3 NewGenIvf Group Ltd For: Apr 03 Filed by: CHARDAN CAPITAL MARKETS LLC
Nov 7, 2024 06:30AM Ocugen Secures $30 Million in Debt Funding
Nov 6, 2024 01:20PM Sonnet BioTherapeutics (SONN) Prices 1.11M Share Offering at $4.50/sh
Nov 6, 2024 01:20PM Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
Nov 5, 2024 04:19PM Chardan Capital Markets Reiterates Buy Rating on Editas Medicine (EDIT)
Oct 23, 2024 04:05PM Coya Therapeutics Announces Closing of $10.0 Million Private Placement
Oct 22, 2024 09:02AM Coya Therapeutics (COYA) Announces 1.38M Share Offering at $7.25/sh
Oct 22, 2024 09:00AM Coya Therapeutics Announces $10.0 Million Private Placement
Oct 10, 2024 02:27AM AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
Sep 30, 2024 01:57PM VivoPower (VVPR) to close F-1 offering
Sep 30, 2024 01:57PM VivoPower decides to close F-1 offering, after successfully raising $4m in gross proceeds from institutional investors
Sep 30, 2024 09:00AM Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences
Sep 30, 2024 08:30AM Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
Sep 25, 2024 04:05PM ARTHEx Biotech Announces Participation in 8th Annual Chardan Genetic Medicines Conference
Sep 25, 2024 09:00AM Avidity Biosciences to Participate in Upcoming Investor Conference
Sep 25, 2024 07:30AM ReCode Therapeutics to Participate in Upcoming Investor Conferences
Sep 24, 2024 08:15AM Coya Therapeutics to Participate in Fireside Chat at the Chardan 8th Annual Genetic Medicines Conference
Sep 24, 2024 07:30AM Atsena Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
Sep 24, 2024 07:30AM Ocugen to Participate in a Fireside Chat at Chardan’s 8th Annual Genetic Medicines Conference
Sep 24, 2024 07:00AM Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
Sep 24, 2024 06:00AM Coave Therapeutics to Present Novel Data Highlighting the Potential of its ALIGATER™ Platform to Enhance the Targeted Delivery of Genetic Medicines at Upcoming Conferences
Sep 23, 2024 04:05PM REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference
Sep 23, 2024 08:56AM Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
Sep 23, 2024 08:00AM Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
Sep 23, 2024 08:00AM Spur Therapeutics to Participate in Chardan’s 8th Annual Genetic Medicines Conference
Sep 23, 2024 07:45AM Affinia Therapeutics to Participate in Upcoming Investor and Industry Conferences
Sep 23, 2024 07:00AM Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
Sep 19, 2024 07:15PM Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
Sep 19, 2024 07:15PM Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
Sep 19, 2024 08:06AM Chardan Capital Markets Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Sep 18, 2024 05:17AM Chardan Capital Markets Starts CervoMed (CRVO) at Buy
Sep 16, 2024 05:30AM Atamyo Therapeutics to Provide Corporate Overviews and Updates on Its Pipeline Progress at 6 Upcoming Conferences in the US and Europe
Sep 13, 2024 09:05AM Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series
View More Recent Stories View Older Stories